One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

Key Takeaways An experimental drug can delay disability progression in advanced multiple sclerosis patientsTolebrutinib ...

The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...